I am a
Home I AM A Search Login

Papers of the Week


Papers: 30 Nov 2019 - 6 Dec 2019


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 12 05


N Engl J Med


381


23

Editor's Pick

Ubrogepant for the Treatment of Migraine.

Authors

Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A
N Engl J Med. 2019 12 05; 381(23):2230-2241.
PMID: 31800988.

Abstract

Ubrogepant is an oral, small-molecule calcitonin gene-related peptide receptor antagonist for acute migraine treatment.